Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Index funds distribute capital gains at occasional dates; knowing when helps you coordinate withdrawals and tax planning effectively.
25,550 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Micron just broke mold by turning AI-driven memory demand into a clear investment thesis. This guide explains why the...
Bitcoin’s price finally entered a defined buy zone this week, signaling a potential shift in sentiment as traders wei...
A recent sale of 25,000 ALHC shares by Alignment Healthcare’s vice chairman has investors wondering about the stock’s...
JPMorgan warns that Michael Saylor’s aggressive BTC purchases, financed through complex instruments, could become a f...
ANSEM surged 299% over the past week, reviving momentum in Solana's memecoin scene and lifting overall ecosystem acti...
Tesla delivers a long-awaited autonomy milestone with unsupervised robotaxi rides in Dallas and Houston, sending TSLA...
As Tesla prepares for its July 22 report, investors are focused on margin expansion, software and services momentum, ...
Europe's quest for cheaper inputs produced resilience gaps. Leaders now pivot to redundancy and security, risking hig...
A prominent SaaS executive warns that AI could erode long-standing moats, while industry data show enduring protectio...
Bandwidth Inc. released a mixed Q4 2025 report that sheds light on customer growth, margins, and the path to profitab...
Investors are watching Viking Therapeutics as its obesity drug candidate approaches key milestones. This article brea...